BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report published on Thursday. The brokerage issued a sell rating on the medical technology company’s stock.

Other equities research analysts have also recently issued reports about the stock. Benchmark reaffirmed a speculative buy rating and set a $0.40 price objective on shares of BIOLASE in a research report on Tuesday, May 14th. Maxim Group cut shares of BIOLASE from a strong-buy rating to a hold rating in a research report on Friday, May 24th.

BIOLASE Stock Performance

Shares of BIOL stock opened at $0.14 on Thursday. The company has a quick ratio of 0.64, a current ratio of 1.17 and a debt-to-equity ratio of 34.06. BIOLASE has a 52 week low of $0.13 and a 52 week high of $10.31. The stock has a market capitalization of $4.80 million, a PE ratio of -0.01 and a beta of 0.74. The firm has a 50 day moving average of $0.16 and a two-hundred day moving average of $0.47.

BIOLASE (NASDAQ:BIOL) last released its quarterly earnings data on Monday, May 13th. The medical technology company reported ($0.36) earnings per share (EPS) for the quarter. The firm had revenue of $10.13 million for the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 43.56%.

Institutional Investors Weigh In On BIOLASE

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC raised its holdings in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 143,537 shares of the medical technology company’s stock after purchasing an additional 131,248 shares during the quarter. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 as of its most recent filing with the SEC. Institutional investors own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.